tradingkey.logo
搜尋

Niagen Bioscience Inc

NAGE
添加自選
3.430USD
+0.100+3.00%
收盤 07/02, 13:00美東報價延遲15分鐘
273.42M總市值
14.69本益比TTM

Niagen Bioscience Inc

3.430
+0.100+3.00%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.00%

5天

+0.29%

1月

-2.00%

6月

-45.12%

今年開始到現在

-46.07%

1年

-73.01%

關鍵數據
3.350今開
3.445最高
464.71K成交量
14.69本益比TTM
10.77本益比動
--股利TTM
0.58%換手率
3.330昨收
3.350最低
1.12M成交額
31.98本益比靜
3.57市淨率
0.00%股息率 TTM
19.05%ROA
14.69052週最高
0.85量比
8.55M淨利潤
79.71M總股本
0.2335每股盈餘TTM
2.19Beta
27.07%ROE
4.16052週最低
2.85%振幅
63.47%毛利率
273.42M總市值
-1.60回報/風險
3.03%風險率

TradingKey Niagen Bioscience Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Niagen Bioscience Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名46/387位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為12.60。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Niagen Bioscience Inc評分

相關信息

行業排名
46 / 387
全市場排名
132 / 4565
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Niagen Bioscience Inc亮點

亮點風險
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
業績高增長
公司營業收入穩步增長,連續3年增長54.87%
估值合理
公司最新PE估值14.69,處於3年歷史合理位

分析師目標

基於 5 分析師
買入
評級
12.600
目標均價
+278.38%
漲幅空間

Niagen Bioscience Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Niagen Bioscience Inc簡介

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代碼NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
網址https://www.niagenbioscience.com/

常見問題

Niagen Bioscience Inc(NAGE)的當前股價是多少?

Niagen Bioscience Inc(NAGE)的當前股價是 3.43。

Niagen Bioscience Inc 的股票代碼是什麼?

Niagen Bioscience Inc的股票代碼是NAGE。

Niagen Bioscience Inc股票的52週最高點是多少?

Niagen Bioscience Inc股票的52週最高點是14.69。

Niagen Bioscience Inc股票的52週最低點是多少?

Niagen Bioscience Inc股票的52週最低點是4.16。

Niagen Bioscience Inc的市值是多少?

Niagen Bioscience Inc的市值是273.42M。

現在Niagen Bioscience Inc(NAGE)的股票是買入、持有還是賣出?

根據分析師評級,Niagen Bioscience Inc(NAGE)的總體評級為買入,目標價格為12.60。

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是多少

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是0.22。